SERVICES

Archive | March 2, 2026

Press Release: How to View a One-Time Photo in WhatsApp Again with WaTracker 1.3.3

NEW YORK, N.Y., March 2, 2026 (SEND2PRESS NEWSWIRE) — iToolab, a leading developer of innovative software solutions for mobile devices, has updated WaTracker to V1.3.3. The new version can help you view one time photo in WhatsApp again and again. WaTracker is different from all other WhatsApp tracking apps in the market.

Continue Reading

Press Release: Christopher Medvidofsky of Dark Matter Technologies named to HousingWire’s Finance Leaders list

JACKSONVILLE, Fla., March 2, 2026 (SEND2PRESS NEWSWIRE) — Dark Matter Technologies (Dark Matter®), an innovative leader in mortgage technology, announced today that Christopher Medvidofsky, director of financial planning and analysis, has been named to the HousingWire Finance Leaders list for 2026.

Continue Reading

Press Release: HitPaw FotorPea V5.3.0 Offers Smarter AI Workflows Across Image Editing, Enhancement and Generation

NEW YORK, N.Y., March 2, 2026 (SEND2PRESS NEWSWIRE) — HitPaw, a leading provider of AI-powered creative tools, announced the release of HitPaw FotorPea V5.3.0, which focuses on making AI image editing smarter and more efficient. This update introduces refined AI models, streamlined workflows, and broader creative applications, helping users achieve high-quality results with less effort.

Continue Reading

Press Release: HIMSS 2026: Future-Proofing the Hospital Digital Front Door – Visit Booth #3461

WESTMINSTER, Colo., March 2, 2026 (SEND2PRESS NEWSWIRE) — The Industry Group (TIG) and the Kiosk Association (KMA) will present a fully integrated, accessibility-focused self-service ecosystem at HIMSS 2026 (Booth #3461, The Venetian Expo, Las Vegas). With the May 11, 2026 HHS Section 504 deadline approaching, healthcare organizations are facing new enforcement realities around digital accessibility […]

Continue Reading

Press Release: CCHR Says Antipsychotic Drug Harm in the Face of Workable Alternatives is Blatantly Ignored

LOS ANGELES, Calif., March 2, 2026 (SEND2PRESS NEWSWIRE) — Seventy-two years after the first antipsychotic, Thorazine, was approved, psychiatry is now seriously discussing the need to deprescribe these drugs. For millions already exposed, that realization comes far too late. Despite decades of mounting evidence of severe and sometimes irreversible harm, new drugs in the same […]

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net